Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cardio Diagnostics Holdings (CDIO) Non-Current Assets (2021 - 2025)

Historic Non-Current Assets for Cardio Diagnostics Holdings (CDIO) over the last 5 years, with Q3 2025 value amounting to $1.9 million.

  • Cardio Diagnostics Holdings' Non-Current Assets rose 38.51% to $1.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $7.1 million, marking a year-over-year decrease of 30.39%. This contributed to the annual value of $1.8 million for FY2024, which is 753.5% up from last year.
  • Per Cardio Diagnostics Holdings' latest filing, its Non-Current Assets stood at $1.9 million for Q3 2025, which was up 38.51% from $1.7 million recorded in Q2 2025.
  • Cardio Diagnostics Holdings' Non-Current Assets' 5-year high stood at $65.6 million during Q3 2022, with a 5-year trough of $298487.0 in Q4 2021.
  • Over the past 5 years, Cardio Diagnostics Holdings' median Non-Current Assets value was $1.7 million (recorded in 2024), while the average stood at $13.3 million.
  • Over the last 5 years, Cardio Diagnostics Holdings' Non-Current Assets had its largest YoY gain of 36664.66% in 2023, and its largest YoY loss of 9936.38% in 2023.
  • Cardio Diagnostics Holdings' Non-Current Assets (Quarter) stood at $298487.0 in 2021, then rose by 21.81% to $363591.0 in 2022, then surged by 366.65% to $1.7 million in 2023, then rose by 7.53% to $1.8 million in 2024, then grew by 2.02% to $1.9 million in 2025.
  • Its Non-Current Assets was $1.9 million in Q3 2025, compared to $1.7 million in Q2 2025 and $1.7 million in Q1 2025.